Inventor · disambiguated record
Martin Edward Mäntylä Noble
Also filed as: NOBLE MARTIN · NOBLE MARTIN E M · NOBLE MARTIN EDWARD MAENTYLAE · NOBLE MARTIN EDWARD MÄNTYLÄ
11 granted patents·5 pending applications·53 citations·filing 2003–2024
89Inventor score
Files withASTEX THERAPEUTICS LTD7CANCER RESEARCH TECH LTD2ISIS INNOVATION2CANCER REC TECH LTD1CANCER RES TECH LTD1
Top patents by PatentIndex Score
16 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0292US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0392US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0488US10414726B2Therapeutic agentsCANCER RESEARCH TECH LTD·Filed 2017·Granted Sep 17, 2019·6 cites·19 claims
- 0587US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 0685US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0783US8618158B2Therapeutic agentsGOLDING BERNARD THOMAS·Filed 2009·Granted Dec 31, 2013·10 cites·19 claims
- 0882US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0974US7989591B2Protein latticeISIS INNOVATION·Filed 2003·Granted Aug 2, 2011·4 cites·34 claims
- 1073US10344017B2Pyrrolcarboxamide derivatives for the inhibition of ERK5CANCER RESEARCH TECH LTD·Filed 2015·Granted Jul 9, 2019·2 cites·20 claims
- 1170US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 1267US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1356US9934937B2Protein layers and their use in electron microscopyISIS INNOVATION·Filed 2014·Granted Apr 3, 2018·0 cites·26 claims
- 1453US2010202672A1Protein Layers And Their Use In Electron MicroscopySINCLAIR JOHN CHARLES·Filed 2008·Application pending·0 cites
- 1552US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 1642US2008097080A1Protein structureSINCLAIR JOHN C·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Edward Mäntylä Noble files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →